2-47414419-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000251.3(MSH2):c.942+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000251.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome Cov.: 25
GnomAD4 genome Cov.: 0
ClinVar
Submissions by phenotype
Lynch syndrome 1 Pathogenic:1
This variant is considered pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. Functional studies indicate this variant impacts protein function [PMID: 8062247, 10777691]. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.942+1G>C intronic pathogenic mutation results from a G to C substitution one nucleotide after coding exon 5 of the MSH2 gene. This variant has been detected in a patient diagnosed with early-onset colon cancer which demonstrated loss of MSH2 and MSH6 protein expression and in conjunction with a somatic pathogenic MSH2 mutation (Ambry internal data). In addition, a different alteration at the same nucleotide position (c.942+1G>T) has been detected in a patient diagnosed with early-onset endometrial cancer which demonstrated high microsatellite instability (MSI-H) and loss of MSH2 and MSH6 protein expression and whose family history fulfilled Amsterdam II criteria (Ambry internal data). In addition to the internal clinical data, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.